Omega Healthcare Investors (OHI)
(Delayed Data from NYSE)
$40.57 USD
+0.39 (0.97%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $40.57 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for Omega Healthcare Investors, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 950 | 878 | 1,063 | 892 | 929 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 950 | 878 | 1,063 | 892 | 929 |
Selling & Adminstrative & Depr. & Amort Expenses | 558 | 566 | 542 | 512 | 377 |
Income After Depreciation & Amortization | 392 | 312 | 520 | 381 | 552 |
Non-Operating Income | 99 | 358 | 130 | 5 | 1 |
Interest Expense | 236 | 233 | 235 | 223 | 209 |
Pretax Income | 256 | 436 | 416 | 162 | 344 |
Income Taxes | 6 | 5 | 4 | 5 | 3 |
Minority Interest | 7 | 12 | 12 | 4 | 11 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | -1 | 7 | 16 | 6 | 11 |
Income From Cont. Operations | 249 | 439 | 428 | 164 | 352 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 242 | 427 | 417 | 159 | 341 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 716 | 652 | 896 | 708 | 857 |
Depreciation & Amortization (Cash Flow) | 324 | 340 | 376 | 327 | 305 |
Income After Depreciation & Amortization | 392 | 312 | 520 | 381 | 552 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 250.45 | 244.29 | 244.34 | 235.10 | 222.13 |
Diluted EPS Before Non-Recurring Items | 1.00 | 1.80 | 1.75 | 0.70 | 1.58 |
Diluted Net EPS (GAAP) | 1.00 | 1.80 | 1.75 | 0.70 | 1.58 |
Fiscal Year end for Omega Healthcare Investors, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 252.75 | 243.30 | 239.32 | 242.03 | 250.19 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 252.75 | 243.30 | 239.32 | 242.03 | 250.19 |
SG&A, R&D, and Dept/Amort Expenses | 95.92 | 116.26 | 138.44 | 135.72 | 142.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | 156.83 | 127.04 | 100.88 | 106.31 | 107.58 |
Non-Operating Income | 16.06 | 2.60 | 20.37 | 49.48 | 13.27 |
Interest Expense | 53.97 | 57.82 | 59.43 | 58.78 | 58.78 |
Pretax Income | 118.92 | 71.83 | 61.82 | 97.01 | 62.08 |
Income Taxes | 1.98 | 2.58 | 4.16 | 1.76 | 1.63 |
Minority Interest | 3.22 | 1.99 | 1.52 | 2.53 | 1.67 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.14 | 0.10 | -1.14 | -1.35 | 1.07 |
Income From Cont. Operations | 117.08 | 69.35 | 56.52 | 93.91 | 61.52 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 113.86 | 67.36 | 55.00 | 91.38 | 59.86 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 261.53 | 257.26 | 256.56 | 255.96 | 246.10 |
Diluted EPS Before Non-Recurring Items | 0.45 | 0.27 | 0.22 | 0.37 | 0.25 |
Diluted Net EPS (GAAP) | 0.45 | 0.27 | 0.23 | 0.37 | 0.25 |